» Articles » PMID: 35482922

Needleless Administration of Advanced Therapies into the Skin Via the Appendages Using a Hypobaric Patch

Abstract

Advanced therapies are commonly administered via injection even when they act within the skin tissue, and this increases the chances of off-target effects. Here we report the use of a skin patch containing a hypobaric chamber that induces skin dome formation to enable needleless delivery of advanced therapies directly into porcine, rat, and mouse skin. Finite element method modeling showed that the hypobaric chamber in the patch opened the skin appendages by 32%, thinned the skin, and compressed the appendage wall epithelia. These changes allowed direct delivery of an H1N1 vaccine antigen and a diclofenac nanotherapeutic into the skin. Fluorescence imaging and infrared mapping of the skin showed needleless delivery via the appendages. The in vivo utility of the patch was demonstrated by a superior immunoglobulin G response to the vaccine antigen in mice compared to intramuscular injection and a 70% reduction in rat paw swelling in vivo over 5 h with diclofenac without skin histology changes.

Citing Articles

A Bioinspired and Cost-Effective Device for Minimally Invasive Blood Sampling.

Zoratto N, Klein-Cerrejon D, Gao D, Inchiparambil T, Sachs D, Luo Z Adv Sci (Weinh). 2024; 11(18):e2308809.

PMID: 38450888 PMC: 11095219. DOI: 10.1002/advs.202308809.


In-Silico Modelling of Transdermal Delivery of Macromolecule Drugs Assisted by a Skin Stretching Hypobaric Device.

Sebastia-Saez D, Benaouda F, Lim C, Lian G, Jones S, Cui L Pharm Res. 2022; 40(1):295-305.

PMID: 36348132 PMC: 9911480. DOI: 10.1007/s11095-022-03423-7.


Formulation and Evaluation of Diclofenac Potassium Gel in Sports Injuries with and without Phonophoresis.

Bukhari K, Khan I, Ishaq S, Iqbal M, Alqahtani A, Alqahtani T Gels. 2022; 8(10).

PMID: 36286113 PMC: 9601609. DOI: 10.3390/gels8100612.

References
1.
Rouphael N, Paine M, Mosley R, Henry S, McAllister D, Kalluri H . The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial. Lancet. 2017; 390(10095):649-658. PMC: 5578828. DOI: 10.1016/S0140-6736(17)30575-5. View

2.
Ferreira S, Lorenzetti B, Poole S . Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br J Pharmacol. 1993; 110(3):1227-31. PMC: 2175796. DOI: 10.1111/j.1476-5381.1993.tb13946.x. View

3.
Shoji Y, Chichester J, Jones M, Manceva S, Damon E, Mett V . Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza. Hum Vaccin. 2011; 7 Suppl:41-50. DOI: 10.4161/hv.7.0.14561. View

4.
Petchsangsai M, Rojanarata T, Opanasopit P, Ngawhirunpat T . The combination of microneedles with electroporation and sonophoresis to enhance hydrophilic macromolecule skin penetration. Biol Pharm Bull. 2014; 37(8):1373-82. DOI: 10.1248/bpb.b14-00321. View

5.
Nair B, Taylor-Gjevre R . A Review of Topical Diclofenac Use in Musculoskeletal Disease. Pharmaceuticals (Basel). 2016; 3(6):1892-1908. PMC: 4033958. DOI: 10.3390/ph3061892. View